Submitted by Anonymous (not verified) on 16 August 2023 - 8:15
Human medicines European public assessment report (EPAR): Buvidal, buprenorphine, Opioid-Related Disorders, Date of authorisation: 20/11/2018, Revision: 8, Status: Authorised
Source: